Silver Book Fact

~One-third of shingles death preventable with vaccine

Approximately one-third of shingles deaths may be preventable through vaccination.

Mahamud, Abdirahman, Mona Marin, Steven P. Nickell, Trevor Shoemaker, John X. Zhang, et al. Herpes Zoster-Related Deaths in the United States: Validity of death certificates and mortality rates, 1979-2007. Clin Infect Dis. 2012; 55(7): 960-66. http://cid.oxfordjournals.org/content/55/7/960.full

Reference

Title
Herpes Zoster-Related Deaths in the United States: Validity of death certificates and mortality rates, 1979-2007
Publication
Clin Infect Dis
Publication Date
2012
Authors
Mahamud, Abdirahman, Mona Marin, Steven P. Nickell, Trevor Shoemaker, John X. Zhang, et al.
Volume & Issue
Volume 55, Issue 7
Pages
960-66
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Future Value

Related Facts

  • Significant savings from zoster vaccine
    In a cost-effectiveness analysis, investigators estimated the zoster vaccine cost $44,000 per quality-adjusted life year saved for a 70-year-old woman.  
  • Potential value of pneumonia vaccine
    Use of PCV13 (13-valent pneumococcal conjugate vaccine) in older adults is estimated to have the potential to reduce total healthcare costs by $3.5 billion and total societal costs by $7.4…  
  • Economic value from flu vaccine in elderly
    As over 60% of the economic burden of influenza falls on those ages 65 and older, programs to reduce the impact of influenza on older Americans would have the greatest…  
  • Use of pneumonia vaccine in children reduced rates in adults age 65+
    Within a year of introduction of PCV7 (7-valent pneumococcal conjugate vaccine) for use in the U.S. in infants, children under 2 years, and high risk children ages 2 to 4;…  
  • Vaccines in development 2013
    Biopharmaceutical research companies are developing 271 vaccines for infectious diseases, cancer, neurological disorders, allergies, and other diseases.